- Cash
Volume Analysis
SPOT Pivot Levels
| Type | Classic | Fibonacci |
|---|---|---|
| R1 | 351.7 | 351.65 |
| R2 | 365.8 | 357.05 |
| R3 | 374.6 | 365.8 |
| PP | 342.9 | 342.9 |
| S1 | 351.7 | 351.65 |
| S2 | 320 | 328.75 |
| S3 | 305.9 | 320 |
Ratios
| Particulars | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|
| ROCE | - | 14.12 | - | 12.93 | - |
| ROE | - | 14.19 | - | 12.57 | - |
| EPS | 3.71 | 4.58 | 5.33 | 6.74 | 4.22 |
Peer Comparison
| Scrip Name | Price | Daily change | M Cap | PE Ratio | 1 Year Return |
|---|
Corporate Action
- Announcements
- Board Meetings
- Dividends
- Bonus
- Splits
- Rights
- AGM/EGM
- Credit Rating
About Aarti Drugs Ltd
Aarti Drugs Limited (ADL), incorporated in September, 1984 is a prominent manufacturer of APIs, Pharma Intermediates, and Specialty Chemicals. The Company operates as part of the Aarti Group, a conglomerate with a net worth of USD 900 million. With over 50 compounds for Antibiotics, Anti Protozoal, Anti-Inflammatory, Anti-diabetic, Anti Fungal and Cardioprotectant therapeutic segments, the Company...
ISIN :INE767A01016
Registered Office
Plot No N-198 MIDC Tarapur,Pamtembhi Village Palghar Tal
Contact number
+ 91-22-24072249
Registrars
MUFG Intime India Pvt Ltd
C-101 247 Park L B S Marg Vikhroli West Mumbai-400083
C-101 247 Park L B S Marg Vikhroli West Mumbai-400083
Contact number
+ 91-22-49186000
Management
Chandrakant V. Gogri (Chairman)
Open IPO’s
FAQs
The share price of Aarti Drugs Ltd on the BSE is - as on -